Position in SNY
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$5,263,616
+$849,686 QoQ
Shares Held
109,249
+19.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HANTZ FINANCIAL SERVICES, INC. holds $94,295,990 across 14 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
84,317 | $21,413,988 | |
| 2 | LLY |
ELI LILLY & Co
|
10,017 | $12,014,691 | |
| 3 | ABBV |
AbbVie Inc.
|
45,381 | $11,419,674 | |
| 4 | NVS |
Novartis AG
|
68,779 | $10,779,044 | |
| 5 | MRK |
Merck & Co., Inc.
|
66,636 | $8,562,726 | |
| 6 | GSK |
GSK plc
|
159,568 | $8,364,554 | |
| 7 | NVO |
Novo Nordisk A S
|
117,306 | $5,623,649 | |
| 8 | AZN |
Astrazeneca PLC
|
23,610 | $4,476,928 |
All Filings in SNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,263,616 | 109,249 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $4,413,930 | 91,084 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,815,270 | 80,832 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,729,708 | 56,504 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $2,694,302 | 48,581 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,358,639 | 48,904 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2,879,137 | 49,959 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,406,737 | 49,603 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $2,467,956 | 50,781 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $2,386,841 | 47,996 | Shares | Sole | 2024-08-06 | |
| 2023-09-30 | $2,243,063 | 41,817 | Shares | Sole | 2024-08-06 | |
| 2023-06-30 | $2,235,556 | 41,476 | Shares | Sole | 2024-08-06 | |
| 2023-03-31 | $2,253,641 | 41,412 | Shares | Sole | 2024-08-06 | |
| 2022-12-31 | $1,977,106 | 40,824 | Shares | Sole | 2024-08-06 | |
| 2022-09-30 | $1,540,874 | 40,528 | Shares | Sole | 2024-08-06 | |
| 2022-06-30 | $2,013,757 | 40,251 | Shares | Sole | 2024-08-06 | |
| 2022-03-31 | $1,991,992 | 38,800 | Shares | Sole | 2024-08-06 | |
| 2021-12-31 | $1,751,095 | 34,952 | Shares | Sole | 2024-08-06 | |
| 2021-09-30 | $1,560,364 | 32,366 | Shares | Sole | 2024-08-06 | |
| 2021-06-30 | $1,467,792 | 27,873 | Shares | Sole | 2024-08-06 | |
| 2021-03-31 | $1,263,801 | 25,552 | Shares | Sole | 2024-08-06 | |
| 2020-12-31 | $866,116 | 17,825 | Shares | Sole | 2024-08-06 | |
| 2020-09-30 | $974,803 | 19,430 | Shares | Sole | 2024-08-06 | |
| 2020-06-30 | $1,118,352 | 21,907 | Shares | Sole | 2024-08-06 | |
| 2020-03-31 | $1,021,911 | 23,374 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||